Table 2– Anthropometric characteristics and baseline lung function data for the subjects included at each centre
Centre
C1C2C3C4C5
Subjects n (% male)66 (52)61 (46)71 (49)108 (50)62 (47)
Age years47.9±17.342.6±15.2*49.1±17.454.8±15.7*49.5±17.3
Height cm171.8±9.9174.7±9.0*170.3±10.8170.5±9.8170.8±9.2
BMI kg·m−226.3±4.224.0±3.1*25.4±4.226.5±4.625.5±3.6
FEV1 L3.6±1.03.8±0.9#3.4±0.93.1±0.9*3.4±0.9
FEV1 % pred105±13102±12102±1295±13***104±13
FEV1 z-score0.39±0.950.15±0.930.17±0.90-0.33±0.88***0.30±0.93
VC L4.4±1.24.7±1.1#4.2±1.23.9±1.1*4.4±1.1
VC % pred104±12103±10101±1295±12***107±12#
VC z-score0.25±0.870.19±0.770.04±0.88-0.36±0.82***0.43±0.83#
FEV1/VC %81±580±782±679±678±6+
FEV1/VC z-score0.16±0.72-0.08±1.070.17±0.830.00±0.78-0.28±0.74§
  • Data are presented as mean±sd, unless otherwise stated. The Global Lungs Initiative reference equations [13] were used to express the spirometry data as percentages of those predicted (% pred) and as z-scores. C1: Antwerp, Belgium; C2: Enschede, the Netherlands; C3: Szeged, Hungary; C4: Perth, Australia; C5: Maastricht, the Netherlands; BMI: body mass index; FEV1: forced expiratory volume in 1 s; VC: vital capacity. *: p<0.05; ***: p<0.001 versus all the other centres; #: p<0.01 versus the data from C3; : p<0.05 versus the data from C1 and C3; +: p<0.05 versus the data from C1, C2 and C3; §: p<0.05 versus the data from C1, C3 and C4.